Johnson & Johnson Asks for Emergency Use Authorization of Its COVID-19 Vaccine

Johnson & Johnson Asks for Emergency Use Authorization of Its COVID-19 Vaccine
A vial of the Janssen COVID-19 vaccine by Johnson & Johnson in July 2020. Johnson & Johnson via AP
|Updated:

Johnson & Johnson asked U.S. regulators Thursday to clear the world’s first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce supplies.

J&J’s vaccine was safe and offered strong protection against moderate to severe COVID-19, according to preliminary results from a massive international study.